These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 22850870)
1. Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up. Otto S; Seeber M; Fujita B; Kretzschmar D; Ferrari M; Goebel B; Figulla HR; Poerner TC Basic Res Cardiol; 2012 Sep; 107(5):289. PubMed ID: 22850870 [TBL] [Abstract][Full Text] [Related]
2. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Bahrmann P; Werner GS; Heusch G; Ferrari M; Poerner TC; Voss A; Figulla HR Circulation; 2007 Feb; 115(5):600-8. PubMed ID: 17261655 [TBL] [Abstract][Full Text] [Related]
3. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis. Hong YJ; Mintz GS; Kim SW; Lee SY; Okabe T; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ JACC Cardiovasc Imaging; 2009 Apr; 2(4):458-68. PubMed ID: 19580729 [TBL] [Abstract][Full Text] [Related]
5. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study. Talarico GP; Brancati M; Burzotta F; Porto I; Trani C; De Vita M; Todaro D; Giammarinaro M; Leone AM; Niccoli G; Andreotti F; Mazzari MA; Schiavoni G; Crea F J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):245-51. PubMed ID: 19262211 [TBL] [Abstract][Full Text] [Related]
6. Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Böse D; von Birgelen C; Zhou XY; Schmermund A; Philipp S; Sack S; Konorza T; Möhlenkamp S; Leineweber K; Kleinbongard P; Wijns W; Heusch G; Erbel R Basic Res Cardiol; 2008 Nov; 103(6):587-97. PubMed ID: 18787802 [TBL] [Abstract][Full Text] [Related]
7. Effect of intracoronary nicardipine on cardiac enzymes after elective percutaneous coronary intervention. Arora S; Alfayoumi F; Khawaja AT; Dua A; Srinivasan V; Gradman AH Clin Cardiol; 2009 Jun; 32(6):315-20. PubMed ID: 19569065 [TBL] [Abstract][Full Text] [Related]
13. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease. Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974 [TBL] [Abstract][Full Text] [Related]
14. Troponin I elevation and cardiac events after percutaneous coronary intervention. Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677 [TBL] [Abstract][Full Text] [Related]
15. Prognostic role of cardiac troponin I after percutaneous coronary intervention in stable coronary disease. Nageh T; Sherwood RA; Harris BM; Thomas MR Heart; 2005 Sep; 91(9):1181-5. PubMed ID: 16103554 [TBL] [Abstract][Full Text] [Related]
16. Troponin I Elevation after Elective Percutaneous Coronary Interventions: Prevalence and Risk Factors. Dev A; Das PK; Bhattacharjee B; Hossan MS; Mahmud I; Uddin MN; Rahim MA; Bhowmick B; Hasan MN Mymensingh Med J; 2023 Jul; 32(3):704-713. PubMed ID: 37391963 [TBL] [Abstract][Full Text] [Related]
17. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes. Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564 [TBL] [Abstract][Full Text] [Related]
18. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention. Sattler KJ; Herrmann J; Yün S; Lehmann N; Wang Z; Heusch G; Sack S; Erbel R; Levkau B Eur Heart J; 2009 Aug; 30(15):1894-902. PubMed ID: 19474052 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of intracoronary adenosine to prevent periprocedural myonecrosis in elective percutaneous coronary intervention (from the PREVENT-ICARUS Trial). De Luca G; Iorio S; Venegoni L; Marino P Am J Cardiol; 2012 Jan; 109(2):202-7. PubMed ID: 22000773 [TBL] [Abstract][Full Text] [Related]
20. Five-year outcomes of surgical or percutaneous myocardial revascularization in diabetic patients. Contini GA; Nicolini F; Fortuna D; Pacini D; Gabbieri D; Vignali L; Valgimigli M; Manari A; Zussa C; Guastaroba P; De Palma R; Grilli R; Gherli T Int J Cardiol; 2013 Sep; 168(2):1028-33. PubMed ID: 23164591 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]